help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haruta, T.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haruta, T.
Right arrow Articles by Kobayashi, M.
Molecular Endocrinology 14 (6): 783-794
Copyright © 2000 by The Endocrine Society

A Rapamycin-Sensitive Pathway Down-Regulates Insulin Signaling via Phosphorylation and Proteasomal Degradation of Insulin Receptor Substrate-1

Tetsuro Haruta, Tatsuhito Uno, Junko Kawahara, Atsuko Takano, Katsuya Egawa, Prem M. Sharma, Jerrold M. Olefsky and Masashi Kobayashi

First Department of Medicine (T.H., T.U., J.K., A.T., M.K.) Toyama Medical and Pharmaceutical University Toyama, 930-0194, Japan
Department of Medicine (K.E., P.M.S., J.M.O.) Division of Endocrinology and Metabolism and Whittier Diabetes Institute University of California, San Diego La Jolla, California 92093
Veterans Administration Research Service (J.M.O.) San Diego, California 92161

Insulin receptor substrate-1 (IRS-1) is a major substrate of the insulin receptor and acts as a docking protein for Src homology 2 domain containing signaling molecules that mediate many of the pleiotropic actions of insulin. Insulin stimulation elicits serine/threonine phosphorylation of IRS-1, which produces a mobility shift on SDS-PAGE, followed by degradation of IRS-1 after prolonged stimulation. We investigated the molecular mechanisms and the functional consequences of these phenomena in 3T3-L1 adipocytes. PI 3-kinase inhibitors or rapamycin, but not the MEK inhibitor, blocked both the insulin-induced electrophoretic mobility shift and degradation of IRS-1. Adenovirus- mediated expression of a membrane-targeted form of the p110 subunit of phosphatidylinositol (PI) 3-kinase (p110CAAX) induced a mobility shift and degradation of IRS-1, both of which were inhibited by rapamycin. Lactacystin, a specific proteasome inhibitor, inhibited insulin-induced degradation of IRS-1 without any effect on its electrophoretic mobility. Inhibition of the mobility shift did not significantly affect tyrosine phosphorylation of IRS-1 or downstream insulin signaling. In contrast, blockade of IRS-1 degradation resulted in sustained activation of Akt, p70 S6 kinase, and mitogen-activated protein (MAP) kinase during prolonged insulin treatment. These results indicate that insulin-induced serine/threonine phosphorylation and degradation of IRS-1 are mediated by a rapamycin-sensitive pathway, which is downstream of PI 3-kinase and independent of ras/MAP kinase. The pathway leads to degradation of IRS-1 by the proteasome, which plays a major role in down-regulation of certain insulin actions during prolonged stimulation.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
C. C. Dibble, J. M. Asara, and B. D. Manning
Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Mol. Cell. Biol., November 1, 2009; 29(21): 5657 - 5670.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Tzatsos
Raptor Binds the SAIN (Shc and IRS-1 NPXY Binding) Domain of Insulin Receptor Substrate-1 (IRS-1) and Regulates the Phosphorylation of IRS-1 at Ser-636/639 by mTOR
J. Biol. Chem., August 21, 2009; 284(34): 22525 - 22534.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Hamada, K. Hara, T. Hamada, H. Yasuda, H. Moriyama, R. Nakayama, M. Nagata, and K. Yokono
Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic {beta}-Cells Leads to Increased {beta}-Cell Mass and Prevention of Hyperglycemia
Diabetes, June 1, 2009; 58(6): 1321 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. S.P. Yuen, E. Akkaya, Y. Wang, M. Takiguchi, S. Peak, M. Sullivan, A. S. Protheroe, and V. M. Macaulay
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
Mol. Cancer Ther., June 1, 2009; 8(6): 1448 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. Scazzocchio, R. Vari, M. D'Archivio, C. Santangelo, C. Filesi, C. Giovannini, and R. Masella
Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
J. Lipid Res., May 1, 2009; 50(5): 832 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Boura-Halfon and Y. Zick
Phosphorylation of IRS proteins, insulin action, and insulin resistance
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E581 - E591.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Adochio, J. W. Leitner, R. Hedlund, and B. Draznin
Rescuing 3T3-L1 Adipocytes from Insulin Resistance Induced by Stimulation of Akt-Mammalian Target of Rapamycin/p70 S6 Kinase (S6K1) Pathway and Serine Phosphorylation of Insulin Receptor Substrate-1: Effect of Reduced Expression of p85{alpha} Subunit of Phosphatidylinositol 3-Kinase and S6K1 Kinase
Endocrinology, March 1, 2009; 150(3): 1165 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Ikubo, T. Wada, K. Fukui, M. Ishiki, H. Ishihara, T. Asano, H. Tsuneki, and T. Sasaoka
Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-{alpha}-induced insulin resistance in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E157 - E164.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Zhang, Z. Gao, J. Yin, M. J. Quon, and J. Ye
S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-{alpha} Signaling through IKK2
J. Biol. Chem., December 19, 2008; 283(51): 35375 - 35382.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. M. Miller, J. R. Brestoff, C. B. Phelps, E. Z. Berk, and T. H. Reynolds IV
Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1431 - R1438.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S. R. Parathath, L. A. Mainwaring, A. Fernandez-L, D. O. Campbell, and A. M. Kenney
Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors
Development, October 1, 2008; 135(19): 3291 - 3300.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. A. Robinson and M. G. Buse
Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E870 - E881.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Meske, F. Albert, and T. G. Ohm
Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3 -dependent Phosphorylation of Tau
J. Biol. Chem., January 4, 2008; 283(1): 100 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Tremblay, S. Brule, S. Hee Um, Y. Li, K. Masuda, M. Roden, X. J. Sun, M. Krebs, R. D. Polakiewicz, G. Thomas, et al.
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance
PNAS, August 28, 2007; 104(35): 14056 - 14061.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
P. Newsholme, E. P. Haber, S. M. Hirabara, E. L. O. Rebelato, J. Procopio, D. Morgan, H. C. Oliveira-Emilio, A. R. Carpinelli, and R. Curi
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity
J. Physiol., August 15, 2007; 583(1): 9 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Oshiro, R. Takahashi, K.-i. Yoshino, K. Tanimura, A. Nakashima, S. Eguchi, T. Miyamoto, K. Hara, K. Takehana, J. Avruch, et al.
The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1
J. Biol. Chem., July 13, 2007; 282(28): 20329 - 20339.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Ishizuka, I. Usui, Y. Kanatani, A. Bukhari, J. He, S. Fujisaka, Y. Yamazaki, H. Suzuki, K. Hiratani, M. Ishiki, et al.
Chronic Tumor Necrosis Factor-{alpha} Treatment Causes Insulin Resistance via Insulin Receptor Substrate-1 Serine Phosphorylation and Suppressor of Cytokine Signaling-3 Induction in 3T3-L1 Adipocytes
Endocrinology, June 1, 2007; 148(6): 2994 - 3003.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. T. Kurmasheva, F. C. Harwood, and P. J. Houghton
Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors
Mol. Cancer Ther., May 1, 2007; 6(5): 1620 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Wang, X. Mao, L. Wang, M. Liu, M. D. Wetzel, K.-L. Guan, L. Q. Dong, and F. Liu
Adiponectin Sensitizes Insulin Signaling by Reducing p70 S6 Kinase-mediated Serine Phosphorylation of IRS-1
J. Biol. Chem., March 16, 2007; 282(11): 7991 - 7996.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Kanatani, I. Usui, K. Ishizuka, A. Bukhari, S. Fujisaka, M. Urakaze, T. Haruta, T. Kishimoto, T. Naka, and M. Kobayashi
Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression: Potential Mechanisms for Its Effects on Insulin Sensitivity and Adiponectin Expression
Diabetes, March 1, 2007; 56(3): 795 - 803.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. E. Cleasby, T. A. Reinten, G. J. Cooney, D. E. James, and E. W. Kraegen
Functional Studies of Akt Isoform Specificity in Skeletal Muscle in Vivo; Maintained Insulin Sensitivity Despite Reduced Insulin Receptor Substrate-1 Expression
Mol. Endocrinol., January 1, 2007; 21(1): 215 - 228.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Jager, T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti
Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
Endocrinology, January 1, 2007; 148(1): 241 - 251.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
E. Roudier, O. Mistafa, and U. Stenius
Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs.
Mol. Cancer Ther., November 1, 2006; 5(11): 2706 - 2715.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. W. Arvisais, A. Romanelli, X. Hou, and J. S. Davis
AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2{alpha}
J. Biol. Chem., September 15, 2006; 281(37): 26904 - 26913.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Draznin
Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85{alpha}: The Two Sides of a Coin.
Diabetes, August 1, 2006; 55(8): 2392 - 2397.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. E. O'Reilly, F. Rojo, Q.-B. She, D. Solit, G. B. Mills, D. Smith, H. Lane, F. Hofmann, D. J. Hicklin, D. L. Ludwig, et al.
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
Cancer Res., February 1, 2006; 66(3): 1500 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. He, I. Usui, K. Ishizuka, Y. Kanatani, K. Hiratani, M. Iwata, A. Bukhari, T. Haruta, T. Sasaoka, and M. Kobayashi
Interleukin-1{alpha} Inhibits Insulin Signaling with Phosphorylating Insulin Receptor Substrate-1 on Serine Residues in 3T3-L1 Adipocytes
Mol. Endocrinol., January 1, 2006; 20(1): 114 - 124.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. L. Hilder, L. A. Baer, P. M. Fuller, C. A. Fuller, R. E. Grindeland, C. E. Wade, and L. M. Graves
Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle
J Appl Physiol, December 1, 2005; 99(6): 2181 - 2188.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Kim, C. M. van Golen, and E. L. Feldman
Insulin-Like Growth Factor I Induces Preferential Degradation of Insulin Receptor Substrate-2 through the Phosphatidylinositol 3-Kinase Pathway in Human Neuroblastoma Cells
Endocrinology, December 1, 2005; 146(12): 5350 - 5357.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
V. Gaussin and C. Depre
Myostatin, the cardiac chalone of insulin-like growth factor-1
Cardiovasc Res, December 1, 2005; 68(3): 347 - 349.
[Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
I. Usui, T. Imamura, J. L. Babendure, H. Satoh, J.-C. Lu, C. J. Hupfeld, and J. M. Olefsky
G Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both G{alpha}q/11 and Insulin Receptor Substrate-1 Pathways in 3T3-L1 Adipocytes
Mol. Endocrinol., November 1, 2005; 19(11): 2760 - 2768.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. Hedhli, M. Pelat, and C. Depre
Protein turnover in cardiac cell growth and survival
Cardiovasc Res, November 1, 2005; 68(2): 186 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Shi, H. Yan, P. Frost, J. Gera, and A. Lichtenstein
Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade
Mol. Cancer Ther., October 1, 2005; 4(10): 1533 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Tremblay, M. Krebs, L. Dombrowski, A. Brehm, E. Bernroider, E. Roth, P. Nowotny, W. Waldhausl, A. Marette, and M. Roden
Overactivation of S6 Kinase 1 as a Cause of Human Insulin Resistance During Increased Amino Acid Availability
Diabetes, September 1, 2005; 54(9): 2674 - 2684.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. Taniyama, H. Hitomi, A. Shah, R. W. Alexander, and K. K. Griendling
Mechanisms of Reactive Oxygen Species-Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1142 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J. A. J. Martyn, and M. Kaneki
Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells
J. Biol. Chem., April 8, 2005; 280(14): 14203 - 14211.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
K. Inoki, H. Ouyang, Y. Li, and K.-L. Guan
Signaling by Target of Rapamycin Proteins in Cell Growth Control
Microbiol. Mol. Biol. Rev., March 1, 2005; 69(1): 79 - 100.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Tremblay, A. Gagnon, A. Veilleux, A. Sorisky, and A. Marette
Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes
Endocrinology, March 1, 2005; 146(3): 1328 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Khamzina, A. Veilleux, S. Bergeron, and A. Marette
Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance
Endocrinology, March 1, 2005; 146(3): 1473 - 1481.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Briaud, L. M. Dickson, M. K. Lingohr, J. F. McCuaig, J. C. Lawrence, and C. J. Rhodes
Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells
J. Biol. Chem., January 21, 2005; 280(3): 2282 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
B. D. Manning
Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis
J. Cell Biol., November 8, 2004; 167(3): 399 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y.-F. Liu, A. Herschkovitz, S. Boura-Halfon, D. Ronen, K. Paz, D. LeRoith, and Y. Zick
Serine Phosphorylation Proximal to Its Phosphotyrosine Binding Domain Inhibits Insulin Receptor Substrate 1 Function and Promotes Insulin Resistance
Mol. Cell. Biol., November 1, 2004; 24(21): 9668 - 9681.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
I. Usui, T. Imamura, J. Huang, H. Satoh, S. K. Shenoy, R. J. Lefkowitz, C. J. Hupfeld, and J. M. Olefsky
{beta}-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1
Mol. Cell. Biol., October 15, 2004; 24(20): 8929 - 8937.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
L. S. Harrington, G. M. Findlay, A. Gray, T. Tolkacheva, S. Wigfield, H. Rebholz, J. Barnett, N. R. Leslie, S. Cheng, P. R. Shepherd, et al.
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
J. Cell Biol., July 19, 2004; 166(2): 213 - 223.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. E. Hartman, J. C. O'Connor, J. P. Godbout, K. D. Minor, V. R. Mazzocco, and G. G. Freund
Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus
J. Biol. Chem., July 2, 2004; 279(27): 28045 - 28050.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. H. Shen, Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley
Tumor Necrosis Factor {alpha} Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis
J. Biol. Chem., February 27, 2004; 279(9): 7438 - 7446.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Miron, P. Lasko, and N. Sonenberg
Signaling from Akt to FRAP/TOR Targets both 4E-BP and S6K in Drosophila melanogaster
Mol. Cell. Biol., December 15, 2003; 23(24): 9117 - 9126.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
T. E. Harris and J. C. Lawrence Jr.
TOR Signaling
Sci. Signal., December 9, 2003; 2003(212): re15 - re15.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Gual, T. Gonzalez, T. Gremeaux, R. Barres, Y. Le Marchand-Brustel, and J.-F. Tanti
Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes
J. Biol. Chem., July 11, 2003; 278(29): 26550 - 26557.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Gao, A. Zuberi, M. J. Quon, Z. Dong, and J. Ye
Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases
J. Biol. Chem., June 27, 2003; 278(27): 24944 - 24950.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Horike, H. Takemori, Y. Katoh, J. Doi, L. Min, T. Asano, X. J. Sun, H. Yamamoto, S. Kasayama, M. Muraoka, et al.
Adipose-specific Expression, Phosphorylation of Ser794 in Insulin Receptor Substrate-1, and Activation in Diabetic Animals of Salt-inducible Kinase-2
J. Biol. Chem., May 9, 2003; 278(20): 18440 - 18447.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Pirola, S. Bonnafous, A. M. Johnston, C. Chaussade, F. Portis, and E. Van Obberghen
Phosphoinositide 3-Kinase-mediated Reduction of Insulin Receptor Substrate-1/2 Protein Expression via Different Mechanisms Contributes to the Insulin-induced Desensitization of Its Signaling Pathways in L6 Muscle Cells
J. Biol. Chem., April 25, 2003; 278(18): 15641 - 15651.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. W. Greene, H. Sakaue, L. Wang, D. R. Alessi, and R. A. Roth
Modulation of Insulin-stimulated Degradation of Human Insulin Receptor Substrate-1 by Serine 312 Phosphorylation
J. Biol. Chem., February 28, 2003; 278(10): 8199 - 8211.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. V. Lee, R. Schiff, X. Cui, D. Sachdev, D. Yee, A. P. Gilmore, C. H. Streuli, S. Oesterreich, and D. L. Hadsell
New Mechanisms of Signal Transduction Inhibitor Action: Receptor Tyrosine Kinase Down-Regulation and Blockade of Signal Transactivation
Clin. Cancer Res., January 1, 2003; 9(1): 516s - 523s.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, M. J. Quon, and J. Ye
Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor kappa B Kinase Complex
J. Biol. Chem., December 6, 2002; 277(50): 48115 - 48121.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
A. Jaeschke, J. Hartkamp, M. Saitoh, W. Roworth, T. Nobukuni, A. Hodges, J. Sampson, G. Thomas, and R. Lamb
Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent
J. Cell Biol., October 28, 2002; 159(2): 217 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
T. Radimerski, J. Montagne, M. Hemmings-Mieszczak, and G. Thomas
Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling
Genes & Dev., October 15, 2002; 16(20): 2627 - 2632.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Dalle, T. Imamura, D. W. Rose, D. S. Worrall, S. Ugi, C. J. Hupfeld, and J. M. Olefsky
Insulin Induces Heterologous Desensitization of G Protein-Coupled Receptor and Insulin-Like Growth Factor I Signaling by Downregulating {beta}-Arrestin-1
Mol. Cell. Biol., September 1, 2002; 22(17): 6272 - 6285.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley
Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor
Cancer Res., August 15, 2002; 62(16): 4746 - 4756.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. Zhande, J. J. Mitchell, J. Wu, and X. J. Sun
Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1
Mol. Cell. Biol., February 15, 2002; 22(4): 1016 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Shao, H. Yamashita, L. Qiao, B. Draznin, and J. E. Friedman
Phosphatidylinositol 3-Kinase Redistribution Is Associated With Skeletal Muscle Insulin Resistance in Gestational Diabetes Mellitus
Diabetes, January 1, 2002; 51(1): 19 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. P. Sykiotis and A. G. Papavassiliou
Minireview: Serine Phosphorylation of Insulin Receptor Substrate-1: A Novel Target for the Reversal of Insulin Resistance
Mol. Endocrinol., November 1, 2001; 15(11): 1864 - 1869.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Rui, T. L. Fisher, J. Thomas, and M. F. White
Regulation of Insulin/Insulin-like Growth Factor-1 Signaling by Proteasome-mediated Degradation of Insulin Receptor Substrate-2
J. Biol. Chem., October 19, 2001; 276(43): 40362 - 40367.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. G. Richards, D. M. Klotz, M. R. Bush, D. K. Walmer, and R. P. DiAugustine
E2-Induced Degradation of Uterine Insulin Receptor Substrate-2: Requirement for an IGF-I-Stimulated, Proteasome-Dependent Pathway
Endocrinology, September 1, 2001; 142(9): 3842 - 3849.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Takano, I. Usui, T. Haruta, J. Kawahara, T. Uno, M. Iwata, and M. Kobayashi
Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin
Mol. Cell. Biol., August 1, 2001; 21(15): 5050 - 5062.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. S. Bogan, A. E. McKee, and H. F. Lodish
Insulin-Responsive Compartments Containing GLUT4 in 3T3-L1 and CHO Cells: Regulation by Amino Acid Concentrations
Mol. Cell. Biol., July 15, 2001; 21(14): 4785 - 4806.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Simpson, J. Li, D. Liaw, I. Hennessy, J. Oliner, F. Christians, and R. Parsons
PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2
Mol. Cell. Biol., June 15, 2001; 21(12): 3947 - 3958.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
F. Tremblay and A. Marette
Amino Acid and Insulin Signaling via the mTOR/p70 S6 Kinase Pathway. A NEGATIVE FEEDBACK MECHANISM LEADING TO INSULIN RESISTANCE IN SKELETAL MUSCLE CELLS
J. Biol. Chem., October 5, 2001; 276(41): 38052 - 38060.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society